143 related articles for article (PubMed ID: 16598648)
1. Role of soluble interleukin-2 receptor levels in patients with latent tuberculosis.
Shitrit D; Izbicki G; Bar-Gil Shitrit A; Raz M; Sulkes J; Kramer MR
Lung; 2006; 184(1):21-4. PubMed ID: 16598648
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble interleukin-2 receptor: a useful indicator of the clinical course in pulmonary tuberculosis.
Avilés Inglés MJ; Contessotto C; Ontañón Rodriguez J; García Alonso A; Muro Amador M; Canteras Jordana M; Sánchez Gascón F; Alvarez López R
Tuber Lung Dis; 1995 Apr; 76(2):130-5. PubMed ID: 7780095
[TBL] [Abstract][Full Text] [Related]
3. Elevated interleukin-2 receptor level in patients with active pulmonary tuberculosis and the changes following anti-tuberculosis chemotherapy.
Chan CH; Lai CK; Leung JC; Ho AS; Lai KN
Eur Respir J; 1995 Jan; 8(1):70-3. PubMed ID: 7744196
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis.
Takahashi S; Setoguchi Y; Nukiwa T; Kira S
Chest; 1991 Feb; 99(2):310-4. PubMed ID: 1989787
[TBL] [Abstract][Full Text] [Related]
5. [Changes and significance of peripheral blood T cell subsets, soluble interleukin-2 receptor and interferon-gamma in patients with retreatment pulmonary tuberculosis and initial treatment tuberculosis].
Zhang SJ; Xiao HP
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):884-7. PubMed ID: 22333498
[TBL] [Abstract][Full Text] [Related]
6. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion.
Kim YK; Lee SY; Kwon SS; Kim KH; Moon HS; Song JS; Park SH
Lung; 2001; 179(3):175-84. PubMed ID: 11891607
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 and soluble interleukin-2 receptor levels in children with active pulmonary tuberculosis and atypical mycobacterial adenitis.
Nyabenda J; Turneer M; Waelbroeck A; Duvivier A; Toppet M
Eur Cytokine Netw; 1993; 4(1):43-9. PubMed ID: 8490104
[TBL] [Abstract][Full Text] [Related]
8. Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity.
He L; Shu X; Liu X; Ge Y; Li S; Lu X; Wang G
Mediators Inflamm; 2020; 2020():6243019. PubMed ID: 32774147
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
[TBL] [Abstract][Full Text] [Related]
10. Soluble interleukin-2 receptor in patients with glomerular diseases.
Chen HS; Wu MS; Yen TS; Chen WY
Postgrad Med J; 1995 Oct; 71(840):617-22. PubMed ID: 8545291
[TBL] [Abstract][Full Text] [Related]
11. Correlation of serum interleukin-2 receptor-alpha levels with clinical manifestations in pulmonary tuberculosis.
Rajalingam R; Mehra NK; Pande JN; Jain RC; Singla R
Tuber Lung Dis; 1996 Aug; 77(4):374-9. PubMed ID: 8796256
[TBL] [Abstract][Full Text] [Related]
12. [Serum soluble interleukin-2 receptor in patients with pulmonary mycobacterial diseases].
Tada A; Kawahara S; Horita N; Horiba A; Tamaoki A; Okada C; Mishima Y; Soda R; Takahashi K
Kekkaku; 1999 Jun; 74(6):499-505. PubMed ID: 10423961
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
14. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis.
Kart L; Buyukoglan H; Tekin IO; Altin R; Senturk Z; Gulmez I; Demir R; Ozesmi M
Mediators Inflamm; 2003 Feb; 12(1):9-14. PubMed ID: 12745543
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.
Grutters JC; Fellrath JM; Mulder L; Janssen R; van den Bosch JM; van Velzen-Blad H
Chest; 2003 Jul; 124(1):186-95. PubMed ID: 12853522
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
17. Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting.
Bharwani KD; Dirckx M; Stronks DL; Dik WA; Huygen FJPM
Mediators Inflamm; 2020; 2020():6259064. PubMed ID: 33061828
[TBL] [Abstract][Full Text] [Related]
18. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S
Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptor (sIL-2r) level is a limited test for the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.
Naymagon L; Tremblay D; Troy K; Mascarenhas J
Eur J Haematol; 2020 Sep; 105(3):255-261. PubMed ID: 32353917
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
Viviani S; Camerini E; Bonfante V; Santoro A; Balzarotti M; Fornier M; Devizzi L; Verderio P; Valagussa P; Bonadonna G
Br J Cancer; 1998 Mar; 77(6):992-7. PubMed ID: 9528846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
